Scientific Program

ON SITE PROGRAM
ABSTRACT BOOK

Thursday, September 15, 2016

15:00 – 19:00 Registration
Location: Bay View Foyer B
12:00 – 18:30 Committee Meetings
Location: Golden Gate Room
12:00 – 13:00 Education Committee
13:00 – 13:30 Outlier Working Group
13:30 – 14:00 Steering Committee
14:00 – 15:00 Mediastinal WG
15:00 – 16:00 Database Committee
16:00 – 17:00 Biology and Tissue Bank
17:00 – 18:00 Research & Infrastructure (inc. Clinical trials)
18:00 – 18:30 Regional Champions
18:30
Welcome Reception
Location: Exhibit Hall – Bay View A

Friday, September 16, 2016

07:00 – 16:00 Registration
Location: Bay View Foyer B
07:30 – 08:00 Committee Meeting – Membership Committee
Location:Golden Gate
08:25 – 08:30 Opening remarks, introduction of industry attendees
Location: Bay View Room B
08:30 – 10:00 Invited Speaker Session 1: Molecular underpinnings of thymic malignancies
Location: Bay View Room B
Chair: Nicolas Girard, France

  • Molecular analysis of malignancies: Why it matters, how it’s done – Nicolas Girard
  • The biology of thymic malignancies: what we know before TCGA – Nicolas Girard
  • TCGA alternative analysis – Bryan Burt
  • What it means for prognosis/therapy – Gregory Riely
  • Panel discussion: Next steps in trial design – Nicolas Girard, Bryan Burt, Gregory Riely, Heather Wakelee, Sukhmani Padda
10:00-10:30 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall – Bay View A
10:30-12:00 Abstract Session 1: Surgical and Pathological Themes
Location: Bay View Room B
Chair: Joseph Shrager, USA

  • Lymph Nodal Dissection in Thymic Tumors: Preliminary Results of a Multicenter Prospective Study – Zhitao Gu
  • Preoperative Neutrophil-To-Lymphocyte Ratio Is an Independent Predictor of Survival in Thymoma – Masahiro Yanagiya
  • WHO Classification and IASLC/ITMIG Staging Proposal in Thymic Tumors: Real-Life Assessment – Lara Chalabreysse
  • Pathological Central Review of 401 Thymic Epithelial Tumors: The RYTHMIC Network Experience – Thierry Molina
  • Specificity of Histopathological and Clinical Criteria of B3 Thymoma vs Epidermoid Thymic Carcinoma – Thierry Molina
  • Carcinoid-/Hemangiopericytoma-Like Morphology of a Thymoma Suggests More Aggressive Tumor’s Behavior – Malgorzata Szolkowska
12:00-13:30 Lunch
12:30-13:30 Industry Lunch Session
Location: Bay View Room B
13:30-15:00 Invited Speaker Session 2: ITMIG Projects and Updates
Location: Bay View Room B
Chair: Anja Roden, USA

  • Synopsis of retrospective DB projects done or underway – Jim Huang
  • Database report, upgrade, refinement initiatives – Nicolas Girard
  • Biology committee – Nicolas Girard
  • Tissue bank report, infrastructure development – Nicolas Girard
  • Mediastinal working group – Anja Roden
  • Outlier analysis – Robert Korst
  • Social media presence – Nuria Novoa
  • Global Asset project – Marlies Keijzers
15:00 – 15:30 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall – Bay View A
15:30 – 16:30 Abstract Session 2: Imaging and Outcomes Studies
Location: Bay View Room B
Chair: Edith Marom, USA & Hui Liu, China

  • Diffusion-Weighted MR Imaging for Assessment of Mediastinal Lesions – Marcelo Benveniste
  • Quality of Resection and Outcome in Stage III TETs: The French RYTHMIC Network Experience – Maria Bluthgen
  • Recurrence in Thymic Malignancies after Complete Resection: Long-Term Outcome from ChART Database – Hui Liu
  • Long Term Health Related Quality of Life in Patients with Thymic Malignancies – Hiten Naik
16:30 – 16:45 Break
16:45-17:45 Invited Speaker Session 3: Management options for recurrences in pleura and beyond
Location: Bay View Room B
Chair: Andreas Rimner, USA

  • Surgical strategies – Jim Huang
  • Updates in topical agents – Joe Friedberg
  • Radiation Techniques – Andreas Rimner
19:00 ITMIG Networking Dinner

Saturday, September 17, 2016

8:00-9:00 Abstract Session 3: Medical Oncology
Location: Bay View Room B
Chair: Sukhmani Padda, USA & Patrick, Loehrer, USA

  • Chemotherapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort – Nicolas Girard
  • Designing Novel Therapies for Clinical Translation through Predictive Simulation for Thymoma – Sukhmani Padda
  • Safety and Clinical Activity of Avelumab (MSB0010718C; Anti-PD-L1) in Patients with Advanced Thymoma – Arun Rajan
  • Neoadjuvant Treatment with Pasireotide in Primary Inoperable Thymoma to Reduce Tumor Size – Berthold Schalke
9:00-10:15 Abstract Session 4: Basic Science of Thymic Malignancies
Location: Bay View Room B
Chair: Bryan Burt, USA

  • Mesothelin: A Novel Therapeutic Target for Patients with Thymic Carcinoma – Arun Rajan
  • FGFR1 Amplification in Thymic Epithelial Tumors (TET): A Study from 51 Cases – Thierry Molina
  • Bortezomib as a Novel Targeted Therapy for Thymic Carcinoma – Yesim Gokmen-Polar
  • Recurrent Mutations and Copy Number Alterations in Thymoma – Robert Downey
  • PD-L1 Expression in Thymic Epithelial Tumors: A Comparative Analysis – Isabelle Rouquette
10:15-11:45 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall – Bay View A
10:45-12:10 Invited Speaker Session 4: Immunity and Autoimmunity in Thymic Malignancies and Myasthenia Gravis
Location: Bay View Room B
Chair: Alex Marx, Germany

  • Innovations Lecture: Immunology of autoimmunity: Sequencing Antibody Repertoires in Cancer – Bill Robinson
  • Results of randomized trial of thymectomy vs medical management of MG – Joshua Sonnett
  • Implications for development of immune therapies for thymic malignancies – Arun Rajan
  • Panel Discussion
12:10 – 13:30 Lunch
12:15 – 13:15 Advocates Lunch – open to patients and advocates
Location: Bay View B
13:30 – 14:00 Advocates Session
14:00 – 15:30 Tumor Board
Location: Bay View Room B
15:30 – 16:00 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall – Bay View A
16:00-17:00 Invited Speaker Session 5: International Clinical Trials Symposium
Location: Bay View Room B
Chair: Heather Wakelee, USA

  • Japan – Meinoshin Okumura
  • China – Vincent (Wentao) Fang
  • Italy – Giovannella Palmieiri
  • France – Nicolas Girard
  • USA – Patrick Loehrer
  • Panel Discussion
17:00-17:30 Concluding Comments
Location: Bay View Room B
18:00 Informal Dinner (all ITMIG delegates invited, however, dinner expenses are on your own)
Switch To Full Site